Search

everythinglearnresearchcommunity

for

Search:↓

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Ritlecitinib is cost-effective for severe alopecia areata in Japan.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Tofacitinib and ruxolitinib are effective and safe for treating various autoimmune skin and joint disorders.

An 82-year-old man's white hair regained color after taking etretinate for psoriasis.

Certain plant compounds can help prevent and treat a virus in pigs.

Newly designed proteins can effectively degrade specific proteins in cells, offering a potential new therapy method.

Acitretin may cause salivary gland inflammation.

A heart transplant patient developed a skin condition called epidermodysplasia verruciformis after taking immune-suppressing drugs.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Acitretin effectively treats severe hypertrophic lichen planus.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Diphencyprone (DCP) is an effective treatment for severe alopecia areata and resistant warts, with some risks.

Tolvaptan can slow kidney disease progression, but doesn't affect mortality or kidney failure.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

HIV-infected men who have sex with men are at higher risk for aggressive syphilis, but treatment and tests are effective.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Combining TUSV with finasteride effectively treats recurrent hemospermia.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

DA-9401 can protect against finasteride-induced reproductive damage in rats.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

5-ARI therapy may help prevent prostate cancer progression.

A woman with Parkinson's disease experienced hair loss from the Parkinson's medication pramipexole, which improved after stopping the drug.

A woman with severe hair loss was successfully treated with the drug adalimumab.